Webinar :Register now for Commodity Ki Paathshala webinar on ‘FPOs & Agriculture Marketing-The Beginning of a New Era’ on January 22, 4pm
you are here: HomeNewsIndia

India controlling COVID-19 spread better than developed nations as cases, deaths per million lesser when compared

In comparison to the countries like the United States of America where the cases per million is 40,000, India has 6,731 cases per million as of November 28, 2020.

November 28, 2020 / 04:53 PM IST
A firefighter sanitises the premises on the first day of the Durga Puja festival, amidst the COVID-19 pandemic in Kolkata. (Image: Reuters)

A firefighter sanitises the premises on the first day of the Durga Puja festival, amidst the COVID-19 pandemic in Kolkata. (Image: Reuters)

Despite the fact, India registered 93.5 lakh coronavirus cases since its emergence and over 1.36 lakh people succumbing to the disease, India's cases per million and number of deaths per million have been comparatively lesser than most developed nations.

In comparison to the countries like the United States of America where the cases per million are 40,000, India has 6,731 cases per million as of November 28, 2020.

COVID-19 epidemic in UK shrinking, R-rate estimated below 1

Apart from this, India's COVID-19 cases are much lesser than developed countries like the United Kingdom (23,361), France (33,424), Brazil (29,129) and Italy (25,456). With details pouring in every day, these countries have 4-5 times more COVID-19 cases per million.

Apart from these, India's per million deaths of people due to the deadly virus stands at 98, which is comparatively lower than most of the nations.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

In comparison to India, the USA saw 813 deaths per million, while the UK has registered 846 deaths. Similarly, countries like Brazil, France, Spain and Italy have registered 805, 780, 955 and 888 deaths per million. All of these countries have 8-9 times more deaths per million than India due to COVID-19.

As per the current coronavirus curve, a downward trend is clearly visible in the country. India registered almost 97,894 cases in September when COVID-19 was at its peak, but now the daily coronavirus cases have dropped to 43,174 (November 26, 2020).

Meanwhile, Prime Minister Narendra Modi on Saturday visited Bharat Biotech facility in Hyderabad to take stock of the indigenous COVID-19 vaccine being developed by the pharmaceutical firm. He is also supposed to visit the Serum Institute of India in Pune to review COVID-19 vaccine development.
Moneycontrol News
first published: Nov 28, 2020 04:10 pm

stay updated

Get Daily News on your Browser
Sections